Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the adequacy of the funding into Parkinson's Disease research.

Government responsibility for delivering Parkinson’s disease research is shared between the Department of Health and Social Care, with research delivered via the National Institute for Health and Care Research (NIHR), and the Department for Science, Innovation and Technology, with research delivered via UK Research and Innovation.

Between the financial years 2019/20 and 2023/24, the Government spent a total of £79.1 million on research into Parkinson’s disease. Research spend is calculated retrospectively, with a time lag due to annual reporting lapses, and so 2023/24 is the most recent financial year we have data for.

As well as funding research itself, the NIHR invests significantly into research expertise and capacity, specialist facilities, support services, and collaborations to support and deliver research in England. Collectively this forms NIHR infrastructure. NIHR infrastructure enables the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research into Parkinson’s disease. For example, in the financial year 2022/23, the NIHR Clinical Research Network enabled 114 studies related to Parkinson’s disease to be conducted in the National Health Service.

The NIHR continues to welcome funding applications for research into any aspect of human health and care, including Parkinson’s disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.

Welcoming applications on Parkinson's disease to all NIHR programmes enables maximum flexibility both in terms of the amount of research funding a particular area can be awarded, and the type of research which can be funded.